【Bloomberg: Arthur Hayes recently invested heavily in a human longevity company, regularly receiving intravenous stem cell infusion therapy over the past year】 According to Golden Finance, Bloomberg reports that BitMEX co-founder Arthur Hayes is turning his investment focus to the field of human longevity. He has recently made a significant investment in a stem cell company with clinics in Mexico and Bangkok, and has joined its board of directors. Over the past year, he has regularly traveled to receive intravenous infusion therapy, stating he "hopes to extend his life as healthily as possible." Although the company name has not been disclosed due to rebranding, he emphasized: this is the future trend - more and more countries are relaxing regulations on the use of stem cells.